The Bristol Royal Infirmary, also known as the BRI, is a large teaching hospital situated in the centre of Bristol, England. It has links with the nearby University of Bristol and the Faculty of Health and Social Care at the University of the West of England, also in Bristol.

During the past decade, Bristol Royal Infirmary conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 12 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bristol Royal Infirmary" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials, followed by "University College, London" with 5 trials sponsored, "Celgene" with 4 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored and "Institute of Cancer Research, United Kingdom" with 3 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bristol Royal Infirmary" #1 collaborator was "National Health and Medical Research Council, Australia" with 4 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 2 trials as a collaborator, "British Heart Foundation" with 2 trials as a collaborator, "Cancer Research UK" with 2 trials as a collaborator and "Ceric Sàrl" with 2 trials as a collaborator. Other collaborators include 83 different institutions and companies that were collaborators in the rest 91 trials.

According to Clinical.Site data, the most researched conditions in "Bristol Royal Infirmary" are "Crohn Disease" (5 trials), "Prostate Cancer" (4 trials), "Ulcerative Colitis" (4 trials), "Breast Cancer" (3 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Bristol Royal Infirmary" in a lesser frequency.

Most popular intervention types in "Bristol Royal Infirmary" are "Drug" (39 trials), "Other" (15 trials), "Procedure" (13 trials), "Device" (11 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "quality-of-life assessment" (4 trials), "Ozanimod" (3 trials), "adjuvant therapy" (3 trials) and "conventional surgery" (3 trials). Other intervention names were less common.

The vast majority of trials in "Bristol Royal Infirmary" are 66 trials for "All" genders, 6 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Bristol Royal Infirmary". undefined are not yet recruiting, 10 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Bristol Royal Infirmary, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Bristol Royal Infirmary, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 14 trials that are defined as “Not Applicable".